$CERO 3 SEC Filings

Filed On	Filing
21 Apr 2026	Form 3: Francois Eric, Director No securities owned
20 Nov 2024	Form 3: Sloan Stuart M, 10% owner Holds 21,600,442 shares of Common Stock, $0.0001 par value per share
14 Nov 2024	Form 3: Yk Bioventures Opportunities Gp I, Llc, 10% owner and 3 others Holds 25,870,783 shares of Common Stock
11 Oct 2024	Form 3: Patel Shami, Director Holds 1,010,254 shares of Class A Common Stock
02 Oct 2024	Form 3: Kucharchuk Andrew Albert, Chief Financial Officer No securities owned
02 Oct 2024	Form 3: Pierce Kristen, Chief Development Officer No securities owned
16 Feb 2024	Form 3: Rolfe Lindsey, Director No securities owned
16 Feb 2024	Form 3: Rapaport Robyn, Director Holds 50,000 shares of Common Stock
16 Feb 2024	Form 3: Corey Daniel, Director Holds 405,147 shares of Common Stock
16 Feb 2024	Form 3: Carter Charles Ross, Chief Financial Officer
16 Feb 2024	Form 3: Byrnes Michael, Director No securities owned
05 Oct 2021	Form 3: Atwood Brian G, Director No securities owned
05 Oct 2021	Form 3: Phoenix Biotech SPONSOR, Llc, 10% owner Holds 663,263 shares of Class A common stock
05 Oct 2021	Form 3: Ehrlich Christopher B, Director Holds 663,263 shares of Class A common stock
05 Oct 2021	Form 3: Geffken Daniel E., Chief Financial Officer No securities owned
05 Oct 2021	Form 3: Fisher Douglas, President No securities owned
05 Oct 2021	Form 3: Laporte Kathleen, Director No securities owned
05 Oct 2021	Form 3: Loewy Caroline M, Director No securities owned
05 Oct 2021	Form 3: Kosacz Barbara, Director No securities owned

Comments